Highline Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Sell |
544
-39
| -7% | -$2.69K | 0.01% | 158 |
|
|
2025
Q1 | $40.5K | Hold |
583
| – | – | 0.01% | 147 |
|
|
2024
Q4 | $50.2K | Sell |
583
-1,810
| -76% | -$156K | 0.02% | 129 |
|
|
2024
Q3 | $285K | Sell |
2,393
-64
| -3% | -$7.62K | 0.1% | 89 |
|
|
2024
Q2 | $351K | Buy |
2,457
+679
| +38% | +$96.9K | 0.13% | 83 |
|
|
2024
Q1 | $228K | Buy |
1,778
+1,378
| +345% | +$177K | 0.09% | 95 |
|
|
2023
Q4 | $41.4K | Hold |
400
| – | – | 0.02% | 134 |
|
|
2023
Q3 | $36.4K | Buy |
+400
| New | +$36.4K | 0.02% | 124 |
|